These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 27509651

  • 1. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P, Yankova M, Stratieva V, Dimitrov I, Shterev A.
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [Abstract] [Full Text] [Related]

  • 2. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB, Rode L, Ekelund CK, Sundberg K, Kjaergaard S, Zingenberg H, Tabor A.
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [Abstract] [Full Text] [Related]

  • 3. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R, Sarno L, Ispas A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [Abstract] [Full Text] [Related]

  • 4. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [Abstract] [Full Text] [Related]

  • 5. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [Abstract] [Full Text] [Related]

  • 6. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D.
    Fetal Diagn Ther; 2014 Mar; 35(3):185-92. PubMed ID: 24192489
    [Abstract] [Full Text] [Related]

  • 7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D, Langlois S, Douglas Wilson R, SOGC GENETICS COMMITTEE, CCMG PRENATAL DIAGNOSIS COMMITTEE.
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [Abstract] [Full Text] [Related]

  • 8. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernabé E, Heibert Arnlind M.
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [Abstract] [Full Text] [Related]

  • 9. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M, Lindsay C, Blais J, Nshimyumukiza L, Takwoingi Y, Langlois S, Légaré F, Giguère Y, Turgeon AF, Witteman W, Rousseau F.
    Cochrane Database Syst Rev; 2017 Nov 10; 11(11):CD011767. PubMed ID: 29125628
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
    Liang D, Lin Y, Li H, Hu P, Xu ZF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb 25; 55(2):106-111. PubMed ID: 32146739
    [Abstract] [Full Text] [Related]

  • 11. Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers.
    Bestwick JP, Huttly WJ, Wald NJ.
    J Med Screen; 2013 Jun 25; 20(2):57-65. PubMed ID: 23761419
    [Abstract] [Full Text] [Related]

  • 12. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M, Chaveeva P, Stratieva V.
    Akush Ginekol (Sofiia); 2015 Jun 25; 54(7):15-21. PubMed ID: 27025103
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S, Xu H, Uerpairojkit B, Chen F, Charoenvidhya D, Liu H, Petcharaburanin N, Liu Y, Tang S, Wang X, Dansakul S, Thomsopa T, Gao Y, Zhang H, Xu H, Jiang H.
    Prenat Diagn; 2016 Mar 25; 36(3):224-31. PubMed ID: 26748603
    [Abstract] [Full Text] [Related]

  • 14. Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities.
    Syngelaki A, Pergament E, Homfray T, Akolekar R, Nicolaides KH.
    Fetal Diagn Ther; 2014 Mar 25; 35(3):174-84. PubMed ID: 24525399
    [Abstract] [Full Text] [Related]

  • 15. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC, Dumidrascu-Diris D, Francisco C, Fantasia I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Feb 25; 47(2):184-7. PubMed ID: 26387684
    [Abstract] [Full Text] [Related]

  • 16. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M, De Falco L, Torella A, Savarese G, Savarese P, Ruggiero R, Conte A, Fico V, Torella M, Fico A.
    BMC Med Genomics; 2021 Mar 30; 14(1):93. PubMed ID: 33785045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, Zhu Z, Lin M, Liu Q, Tian Z, Zhang H, Chen F, Lau TK, Zhao L, Yi X, Yin Y, Wang W.
    Ultrasound Obstet Gynecol; 2015 May 30; 45(5):530-8. PubMed ID: 25598039
    [Abstract] [Full Text] [Related]

  • 19. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, Oliver K, Rava RP, Sehnert AJ, CARE Study Group.
    N Engl J Med; 2014 Feb 27; 370(9):799-808. PubMed ID: 24571752
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT, Khalil A, Forman M, Hulme R, Mazey R, Mousa HA, Johnstone ED, McKelvey A, Cohen KE, Risley M, Denman W, Kelly B.
    Ultrasound Obstet Gynecol; 2016 Feb 27; 47(2):188-93. PubMed ID: 26493543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.